BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Knapp FF. Rhenium-188--a generator-derived radioisotope for cancer therapy. Cancer Biother Radiopharm. 1998;13:337-349. [PMID: 10851424 DOI: 10.1089/cbr.1998.13.337] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Uccelli L, Martini P, Urso L, Ghirardi T, Marvelli L, Cittanti C, Carnevale A, Giganti M, Bartolomei M, Boschi A. Rhenium Radioisotopes for Medicine, a Focus on Production and Applications. Molecules 2022;27:5283. [DOI: 10.3390/molecules27165283] [Reference Citation Analysis]
2 Suárez-Ortiz GA, Hernández-Correa R, Morales-Moreno MD, Toscano RA, Ramirez-Apan MT, Hernandez-Garcia A, Amézquita-Valencia M, Araiza-Olivera D. Diastereomeric Separation of Chiral fac-Tricarbonyl(iminopyridine) Rhenium(I) Complexes and Their Cytotoxicity Studies: Approach toward an Action Mechanism against Glioblastoma. J Med Chem 2022. [PMID: 35776775 DOI: 10.1021/acs.jmedchem.2c00561] [Reference Citation Analysis]
3 Shinto AS, Karuppusamy KK, Kurup RER, Pandiyan A, Jayaraj AV. Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma. Nucl Med Commun 2021;42:43-50. [PMID: 32956248 DOI: 10.1097/MNM.0000000000001296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ye RR, Chen BC, Lu JJ, Ma XR, Li RT. Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction. J Inorg Biochem 2021;223:111537. [PMID: 34273716 DOI: 10.1016/j.jinorgbio.2021.111537] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
5 Chen P, Li J, Gui J, Liu C, Wang Y, Zhang G, Kuai D, Wu Y, Liu Z, Zuo C, Lv Z, ZhangLi YB, Liu X. Efficacy and safety of 188Re-HEDP in lung cancer patients with bone metastases: a randomized, multicenter, multiple-dose phase IIa study. Int J Clin Oncol 2021;26:1212-20. [PMID: 33847856 DOI: 10.1007/s10147-021-01906-y] [Reference Citation Analysis]
6 Klenner MA, Darwish T, Fraser BH, Massi M, Pascali G. Labeled Rhenium Complexes: Radiofluorination, α-MSH Cyclization, and Deuterium Substitutions. Organometallics 2020;39:2334-51. [DOI: 10.1021/acs.organomet.0c00267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lepareur N, Lacœuille F, Bouvry C, Hindré F, Garcion E, Chérel M, Noiret N, Garin E, Knapp FFR Jr. Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives. Front Med (Lausanne) 2019;6:132. [PMID: 31259173 DOI: 10.3389/fmed.2019.00132] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 18.0] [Reference Citation Analysis]
8 Shukla J, Kalra N, Kumar R, Bhusari P, Chhabra A, Parmar M, Vatsa R, Singh H, Duseja A, Mittal BR. Two Cases of 188Re Microspheres for Inoperable Hepatocellular Carcinoma. Clin Nucl Med 2019;44:e93-5. [DOI: 10.1097/rlu.0000000000002373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Burke BP, Grantham W, Burke MJ, Nichol GS, Roberts D, Renard I, Hargreaves R, Cawthorne C, Archibald SJ, Lusby PJ. Visualizing Kinetically Robust CoIII4L6 Assemblies in Vivo: SPECT Imaging of the Encapsulated [99mTc]TcO4- Anion. J Am Chem Soc 2018;140:16877-81. [PMID: 30485075 DOI: 10.1021/jacs.8b09582] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 9.5] [Reference Citation Analysis]
10 Makris G, Radford LL, Kuchuk M, Gallazzi F, Jurisson SS, Smith CJ, Hennkens HM. NOTA and NODAGA [99mTc]Tc- and [186Re]Re-Tricarbonyl Complexes: Radiochemistry and First Example of a [99mTc]Tc-NODAGA Somatostatin Receptor-Targeting Bioconjugate. Bioconjug Chem 2018;29:4040-9. [PMID: 30412382 DOI: 10.1021/acs.bioconjchem.8b00670] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
11 Chhabra A, Rathore Y, Bhusari P, Vatsa R, Mittal BR, Shukla J. Concentration protocol of rhenium-188 perrhenate eluted from tungsten-188/rhenium-188 generator for the preparation of high-yield rhenium-188-labelled radiopharmaceuticals. Nuclear Medicine Communications 2018;39:957-9. [DOI: 10.1097/mnm.0000000000000893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Baumeister JE, Reinig KM, Barnes CL, Kelley SP, Jurisson SS. Technetium and Rhenium Schiff Base Compounds for Nuclear Medicine: Syntheses of Rhenium Analogues to 99mTc-Furifosmin. Inorg Chem 2018;57:12920-33. [PMID: 30239194 DOI: 10.1021/acs.inorgchem.8b02156] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
13 Allen KJH, Jiao R, Malo ME, Dadachova E. Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188Rhenium. Cancer Biother Radiopharm 2018;33:349-55. [PMID: 30010404 DOI: 10.1089/cbr.2018.2480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Mastren T, Radchenko V, Bach HT, Balkin ER, Birnbaum ER, Brugh M, Engle JW, Gott MD, Guthrie J, Hennkens HM, John KD, Ketring AR, Kuchuk M, Maassen JR, Naranjo CM, Nortier FM, Phelps TE, Jurisson SS, Wilbur DS, Fassbender ME. Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam. Nuclear Medicine and Biology 2017;49:24-9. [DOI: 10.1016/j.nucmedbio.2017.02.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
15 Balkin ER, Gagnon K, Strong KT, Smith BE, Dorman EF, Emery RC, Pauzauskie PJ, Fassbender ME, Cutler CS, Ketring AR, Jurisson SS, Wilbur DS. Deuteron irradiation of W and WO3 for production of high specific activity 186Re: Challenges associated with thick target preparation. Applied Radiation and Isotopes 2016;115:197-207. [DOI: 10.1016/j.apradiso.2016.06.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
16 Chao Y, Wang G, Liang C, Yi X, Zhong X, Liu J, Gao M, Yang K, Cheng L, Liu Z. Rhenium-188 Labeled Tungsten Disulfide Nanoflakes for Self-Sensitized, Near-Infrared Enhanced Radioisotope Therapy. Small 2016;12:3967-75. [PMID: 27345460 DOI: 10.1002/smll.201601375] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
17 Hille C, Kühn FE. Cationic rhenium complexes ligated with N-heterocyclic carbenes – an overview. Dalton Trans 2016;45:15-31. [DOI: 10.1039/c5dt03641k] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
18 Dash A, Knapp Jr FF(. An overview of radioisotope separation technologies for development of 188 W/ 188 Re radionuclide generators providing 188 Re to meet future research and clinical demands. RSC Adv 2015;5:39012-36. [DOI: 10.1039/c5ra03890a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Leonidova A, Gasser G. Underestimated potential of organometallic rhenium complexes as anticancer agents. ACS Chem Biol 2014;9:2180-93. [PMID: 25137157 DOI: 10.1021/cb500528c] [Cited by in Crossref: 175] [Cited by in F6Publishing: 167] [Article Influence: 21.9] [Reference Citation Analysis]
20 Phillips WT, Bao A, Brenner AJ, Goins BA. Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles. Adv Drug Deliv Rev 2014;76:39-59. [PMID: 25016083 DOI: 10.1016/j.addr.2014.07.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 7.0] [Reference Citation Analysis]
21 Dash A, Chakravarty R. Pivotal role of separation chemistry in the development of radionuclide generators to meet clinical demands. RSC Adv 2014;4:42779-803. [DOI: 10.1039/c4ra07218a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
22 Dash A, Chakravarty R. Electrochemical Separation: Promises, Opportunities, and Challenges To Develop Next-Generation Radionuclide Generators To Meet Clinical Demands. Ind Eng Chem Res 2014;53:3766-77. [DOI: 10.1021/ie404369y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
23 Jürgens S, Herrmann WA, Kühn FE. Rhenium and technetium based radiopharmaceuticals: Development and recent advances. Journal of Organometallic Chemistry 2014;751:83-9. [DOI: 10.1016/j.jorganchem.2013.07.042] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 8.3] [Reference Citation Analysis]
24 Boschi A, Uccelli L, Pasquali M, Duatti A, Taibi A, Pupillo G, Esposito J. 188 W/ 188 Re Generator System and Its Therapeutic Applications. Journal of Chemistry 2014;2014:1-14. [DOI: 10.1155/2014/529406] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
25 Chakravarty R, Dash A. Nanomaterial-based adsorbents: the prospect of developing new generation radionuclide generators to meet future research and clinical demands. J Radioanal Nucl Chem 2014;299:741-57. [DOI: 10.1007/s10967-013-2823-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
26 Lo ST, Kumar A, Hsieh JT, Sun X. Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry. Mol Pharm 2013;10:793-812. [PMID: 23294202 DOI: 10.1021/mp3005325] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
27 Chakravarty R, Dash A. Nano Structured Metal Oxides as Potential Sorbents for 188 W/ 188 Re Generator: A Comparative Study. Separation Science and Technology 2013;48:607-16. [DOI: 10.1080/01496395.2012.713433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
28 Ferreira S, Dormehl I, Botelho MF. Radiopharmaceuticals for bone metastasis therapy and beyond: a voyage from the past to the present and a look to the future. Cancer Biother Radiopharm 2012;27:535-51. [PMID: 23075374 DOI: 10.1089/cbr.2012.1258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
29 Ali MC, Suzuki T, Tachibana Y, Sasaki Y, Ikeda Y. Selective extraction of perrhenate anion in nitric acid solution using 2,2′-(imino)bis(N,N′-dioctylacetamide) as an extractant. Separation and Purification Technology 2012;92:77-82. [DOI: 10.1016/j.seppur.2012.03.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
30 Misri R, Saatchi K, Häfeli UO. Nanoprobes for hybrid SPECT/MR molecular imaging. Nanomedicine 2012;7:719-33. [DOI: 10.2217/nnm.12.32] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
31 Lepareur N, Ardisson V, Noiret N, Garin E. (188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside. Int J Mol Imaging 2012;2012:278306. [PMID: 22518301 DOI: 10.1155/2012/278306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
32 Aryal BP, Brugarolas P, He C. Binding of ReO4(-) with an engineered MoO4(2-)-binding protein: towards a new approach in radiopharmaceutical applications. J Biol Inorg Chem 2012;17:97-106. [PMID: 21861186 DOI: 10.1007/s00775-011-0833-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
33 Chakravarty R, Shukla R, Tyagi A, Dash A, Venkatesh M. Nanocrystalline zirconia: A novel sorbent for the preparation of 188W/188Re generator. Applied Radiation and Isotopes 2010;68:229-38. [DOI: 10.1016/j.apradiso.2009.10.031] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
34 Guhlke S, Scheithauer S, Oetjen K, Sartor J, Bender H, Biersack HJ. 188 Re(V)-DMSA: in-vitro and in-vivo studies on the individual stereo isomers. Radiochimica Acta 2004;92:277-83. [DOI: 10.1524/ract.] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Chakravarty R, Dash A, Venkatesh M. Separation of Clinical Grade 188Re from 188W Using Polymer Embedded Nanocrystalline Titania. Chroma 2009;69:1363-72. [DOI: 10.1365/s10337-009-1070-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
36 Chakravarty R, Dash A, Kothari K, Pillai MRA, Venkatesh M. A novel 188W/188Re electrochemical generator with potential for medical applications. Radiochimica Acta 2009;97. [DOI: 10.1524/ract.2009.1612] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
37 De Decker M, Bacher K, Thierens H, Slegers G, Dierckx RA, De Vos F. In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia. Nuclear Medicine and Biology 2008;35:599-604. [DOI: 10.1016/j.nucmedbio.2008.03.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
38 Jeong JM, Knapp F. Use of the Oak Ridge National Laboratory Tungsten-188/Rhenium-188 Generator for Preparation of the Rhenium-188 HDD/Lipiodol Complex for Trans-Arterial Liver Cancer Therapy. Seminars in Nuclear Medicine 2008;38:S19-29. [DOI: 10.1053/j.semnuclmed.2007.10.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
39 El-Mabhouh AA, Mercer JR. 188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases. Eur J Nucl Med Mol Imaging 2008;35:1240-8. [PMID: 18265977 DOI: 10.1007/s00259-008-0728-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
40 Willhauck MJ, Sharif Samani BR, Gildehaus FJ, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Göke B, Morris JC, Spitzweg C. Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. J Clin Endocrinol Metab 2007;92:4451-8. [PMID: 17698909 DOI: 10.1210/jc.2007-0402] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
41 Xiong Q, Chen Y, He L, Deng C, Huang Z, Li J. Study of Apoptosis Induced by 188 Re-DTPA-DG in MCF-7 Breast Carcinoma and A549 Pulmonary Carcinoma Cells. Cancer Biotherapy and Radiopharmaceuticals 2007;22:543-50. [DOI: 10.1089/cbr.2007.367a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
42 Antoccia A, Banzato A, Bello M, Bollini D, Notaristefani FD, Giron C, Mazzi U, Alafort LM, Moschini G, Nadali A, Navarria F, Perrotta A, Rosato A, Tanzarella C, Uzunov N. 188Rhenium-induced cell death and apoptosis in a panel of tumor cell lines. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 2007;571:471-4. [DOI: 10.1016/j.nima.2006.10.137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Dadachova E, Patel MC, Toussi S, Apostolidis C, Morgenstern A, Brechbiel MW, Gorny MK, Zolla-Pazner S, Casadevall A, Goldstein H. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med 2006;3:e427. [PMID: 17090209 DOI: 10.1371/journal.pmed.0030427] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
44 Zimmerman B. Radionuclide metrology in the life sciences: Recent advances and future trends. Applied Radiation and Isotopes 2006;64:1351-9. [DOI: 10.1016/j.apradiso.2006.02.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Divgi C. Editorial: what ails solid tumor radioimmunotherapy? Cancer Biother Radiopharm 2006;21:81-4. [PMID: 16706627 DOI: 10.1089/cbr.2006.21.81] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
46 Kumar A, Srivastava DN, Bal C. Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil. J Vasc Interv Radiol 2006;17:157-61. [PMID: 16415146 DOI: 10.1097/01.rvi.0000195321.20579.f2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
47 Lambert B, de Klerk JM. Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapy. Nucl Med Commun 2006;27:223-9. [PMID: 16479241 DOI: 10.1097/00006231-200603000-00004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
48 Ballot S, Noiret N, Hindré F, Denizot B, Garin E, Rajerison H, Benoit JP. 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution. Eur J Nucl Med Mol Imaging 2006;33:602-7. [PMID: 16450136 DOI: 10.1007/s00259-005-0007-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
49 Lambert B, Bacher K, Defreyne L, Van Vlierberghe H, Jeong JM, Wang RF, van Meerbeeck J, Smeets P, Troisi R, Thierens H, De Vos F, Van de Wiele C. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study. Eur J Nucl Med Mol Imaging 2006;33:344-52. [PMID: 16333675 DOI: 10.1007/s00259-005-1954-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
50 Marczewski B, Dias CR, Moraes V, Osso Junior JA. Liquid kit for preparation of 188rhenium-etidronate. Braz arch biol technol 2005;48:137-40. [DOI: 10.1590/s1516-89132005000700019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
51 Yu J, Häfeli UO, Xia J, Li S, Dong M, Yin D, Wang Y. Radiolabelling of poly(histidine) derivatized biodegradable microspheres with the 188Re tricarbonyl complex [188Re(CO)3(H2O)3]+. Nucl Med Commun 2005;26:453-8. [PMID: 15838429 DOI: 10.1097/00006231-200505000-00010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
52 Unak P, Cetinkaya B, Unak I. Absorbed dose estimates at the cellular level for 186Re and 188Re. Radiation Physics and Chemistry 2005;73:137-46. [DOI: 10.1016/j.radphyschem.2004.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
53 Boschi A, Uccelli L, Duatti A, Colamussi P, Cittanti C, Filice A, Rose AH, Martindale AA, Claringbold PG, Kearney D, Galeotti R, Turner JH, Giganti M. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma. Nucl Med Commun 2004;25:691-9. [PMID: 15208496 DOI: 10.1097/01.mnm.0000130241.22068.45] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
54 Dadachova E, Nosanchuk JD, Shi L, Schweitzer AD, Frenkel A, Nosanchuk JS, Casadevall A. Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin. Proc Natl Acad Sci U S A 2004;101:14865-70. [PMID: 15469923 DOI: 10.1073/pnas.0406180101] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
55 Dadachova E, Carrasco N. The Na/I symporter (NIS): imaging and therapeutic applications. Semin Nucl Med 2004;34:23-31. [PMID: 14735456 DOI: 10.1053/j.semnuclmed.2003.09.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 3.7] [Reference Citation Analysis]
56 Shen D, Marsee D, Schaap J, Yang W, Cho J, Hinkle G, Nagaraja H, Kloos R, Barth R, Jhiang S. Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy. Gene Ther 2004;11:161-9. [DOI: 10.1038/sj.gt.3302147] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
57 Häfeli UO, Yu J, Farudi F, Li Y, Tapolsky G. Radiolabeling of magnetic targeted carriers (MTC) with indium-111. Nuclear Medicine and Biology 2003;30:761-9. [DOI: 10.1016/s0969-8051(03)00077-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
58 Dadachova E, Nakouzi A, Bryan RA, Casadevall A. Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection. Proc Natl Acad Sci U S A 2003;100:10942-7. [PMID: 12930899 DOI: 10.1073/pnas.1731272100] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 3.8] [Reference Citation Analysis]
59 Das T, Chakraborty S, Banerjee S, Samuel G, Sarma HD, Venkatesh M, Pillai MRA. Preparation and animal biodistribution of166Ho labeled DOTA for possible use in intravascular radiation therapy (IVRT). J Labelled Cpd Radiopharm 2003;46:197-209. [DOI: 10.1002/jlcr.657] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
60 Mirzadeh S, Lambrecht F, Lambrecht R. Decay of tungsten-189. Applied Radiation and Isotopes 2002;57:637-40. [DOI: 10.1016/s0969-8043(02)00177-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
61 Dadachov M, Van So L, Lambrecht R, Dadachova E. Development of a titanium tungstate-based 188W/188Re gel generator using tungsten of natural isotopic abundance. Applied Radiation and Isotopes 2002;57:641-6. [DOI: 10.1016/s0969-8043(02)00178-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
62 Rattat D, Schubiger PA, Berke HG, Schmalle H, Alberto R. Dicarbonyl-nitrosyl-complexes of rhenium (Re) and technetium (Tc), a potentially new class of compounds for the direct radiolabeling of biomolecules. Cancer Biother Radiopharm 2001;16:339-43. [PMID: 11603005 DOI: 10.1089/108497801753131426] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
63 Srivastava S, Dadachova E. Recent advances in radionuclide therapy. Semin Nucl Med 2001;31:330-41. [PMID: 11710775 DOI: 10.1053/snuc.2001.27043] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
64 Lou C, Chen ZN, Bian HJ, Li J, Zhou SB. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18. World J Gastroenterol 2002; 8(1): 69-73 [PMID: 11833074 DOI: 10.3748/wjg.v8.i1.69] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
65 Dadachova E, Bouzahzah B, Zuckier L, Pestell R. Rhenium-188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS). Nuclear Medicine and Biology 2002;29:13-8. [DOI: 10.1016/s0969-8051(01)00279-7] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 3.3] [Reference Citation Analysis]
66 Oh SJ, Won KS, Moon DH, Cheon JH, Ha H, Jeong JM, Lee HK. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N′,N′-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation: . Nuclear Medicine Communications 2002;23:75-81. [DOI: 10.1097/00006231-200201000-00012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
67 Zimmerman BE, Cessna JT, Unterweger MP. The standardization of 188W/188Re by 4πβ liquid scintillation spectrometry with the CIEMAT/NIST 3H-standard efficiency tracing method. Applied Radiation and Isotopes 2002;56:315-20. [DOI: 10.1016/s0969-8043(01)00207-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
68 Lisic EC, Phillips M, Ensor D, Nash KL, Beets A, Knapp F. Synthesis of a new bisphosphonic acid ligand (SEDP) and preparation of a 188Re-(Sn)SEDP bone seeking radiotracer. Nuclear Medicine and Biology 2001;28:419-24. [DOI: 10.1016/s0969-8051(00)00205-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
69 Häfeli U, Pauer G, Failing S, Tapolsky G. Radiolabeling of magnetic particles with rhenium-188 for cancer therapy. Journal of Magnetism and Magnetic Materials 2001;225:73-8. [DOI: 10.1016/s0304-8853(00)01230-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
70 Spear SK, Griffin ST, Huddleston JG, Rogers RD. Radiopharmaceutical and Hydrometallurgical Separations of Perrhenate Using Aqueous Biphasic Systems and the Analogous Aqueous Biphasic Extraction Chromatographic Resins. Ind Eng Chem Res 2000;39:3173-80. [DOI: 10.1021/ie990583p] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
71 Knapp F, Guhlke S, Beets AL, Lin W, Stabin M, Amols H, Weinberger J. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes. Cardiovascular Radiation Medicine 1999;1:86-97. [DOI: 10.1016/s1522-1865(98)00009-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]